Company logo

NVCR - NovoCure Limited

NASDAQ -> Healthcare -> Medical Instruments & Supplies
Saint Helier, Jersey
Type: Equity

NVCR price evolution
NVCR
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $242.56 $156.51 $157.49 $186.64
Short term investments $669.79 $766.39 $783.84 $772.07
Net receivables $83.9 $88.3 $91.14 $98.56
Inventory $38.15 $36.81 $33.02 $31.72
Total current assets $1034.41 $1048 $1065.49 $1088.99
Long term investments
Property, plant & equipment $97.7 $85.94 $78.95 $74.2
Goodwill & intangible assets
Total noncurrent assets $111.72 $98.35 $93.53 $85.35
Total investments $669.79 $766.39 $783.84 $772.07
Total assets $1146.13 $1146.35 $1159.02 $1174.34
Current liabilities
Accounts payable $94.39 $79.67 $82.54 $81.47
Deferred revenue $0.81 $1.84
Short long term debt
Total current liabilities $179.12 $157.16 $150.09 $148.78
Long term debt $596.24 $590.04 $587.48 $586.3
Total noncurrent liabilities $604.52 $595.49 $593.25 $593.42
Total debt $596.24 $590.04 $587.48 $586.3
Total liabilities $783.63 $752.65 $743.33 $742.19
Shareholders' equity
Retained earnings -$985.5 -$938.42 -$888.94 -$831.52
Other shareholder equity -$5.47 -$1.99 -$1.98 -$2.69
Total shareholder equity $362.5 $393.7 $415.68 $432.15
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $242.56 $9.7 $209.61 $246.17
Short term investments $669.79 $854.1 $728.9 $607.9
Net receivables $83.9 $106.03 $110.59 $117.94
Inventory $38.15 $29.38 $24.43 $27.42
Total current assets $1034.41 $1111.53 $1073.53 $999.44
Long term investments
Property, plant & equipment $97.7 $68.96 $53.88 $41.63
Goodwill & intangible assets
Total noncurrent assets $111.72 $80.12 $65.97 $52.54
Total investments $669.79 $854.1 $728.9 $607.9
Total assets $1146.13 $1191.65 $1139.49 $1051.98
Current liabilities
Accounts payable $94.39 $85.2 $72.6 $113.61
Deferred revenue $2.88 $6.48 $12.14
Short long term debt
Total current liabilities $179.12 $158.78 $142.6 $113.61
Long term debt $596.24 $565.51 $575.21 $444.2
Total noncurrent liabilities $604.52 $591.7 $586.4 $461.85
Total debt $596.24 $584.27 $575.21 $444.2
Total liabilities $783.63 $750.48 $729 $575.46
Shareholders' equity
Retained earnings -$985.5 -$778.46 -$685.93 -$631.08
Other shareholder equity -$5.47 -$2.43 -$3.17 -$3.83
Total shareholder equity $362.5 $441.17 $410.49 $476.53
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $133.78 $127.32 $126.05 $122.18
Cost of revenue $32.56 $32.09 $34.02 $29.61
Gross Profit $101.23 $95.23 $92.03 $92.57
Operating activities
Research & development $54.31 $53.62 $55.43 $59.7
Selling, general & administrative $98.64 $99.85 $99.27 $93.11
Total operating expenses $152.94 $153.47 $154.69 $152.82
Operating income -$51.72 -$58.24 -$62.66 -$60.25
Income from continuing operations
EBIT -$51.72 -$58.24 -$62.66 -$60.25
Income tax expense $8.54 $1.26 $3.51 $1.98
Interest expense -$13.18 -$10.02 -$8.76 -$9.17
Net income
Net income -$47.08 -$49.48 -$57.42 -$53.06
Income (for common shares) -$47.08 -$49.48 -$57.42 -$53.06
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $509.34 $537.84 $535.03 $494.37
Cost of revenue $128.28 $114.87 $114.88 $106.5
Gross Profit $381.06 $422.97 $420.15 $387.87
Operating activities
Research & development $223.06 $206.09 $201.3 $132.01
Selling, general & administrative $390.87 $306.41 $263.18 $225.45
Total operating expenses $613.93 $512.5 $464.49 $357.46
Operating income -$232.87 -$89.52 -$44.33 $30.4
Income from continuing operations
EBIT -$232.87 -$89.52 -$44.33 $30.4
Income tax expense $15.3 $10.69 $6.28 -$1.71
Interest expense -$41.13 -$7.68 $7.74 $12.3
Net income
Net income -$207.04 -$92.53 -$58.35 $19.81
Income (for common shares) -$207.04 -$92.53 -$58.35 $19.81
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$47.08 -$49.48 -$57.42 -$53.06
Operating activities
Depreciation $2.72 $2.8 $2.72 $2.72
Business acquisitions & disposals
Stock-based compensation $17.44 $26.35 $32.74 $39.08
Total cash flows from operations -$14.56 -$19.31 -$22.74 -$16.73
Investing activities
Capital expenditures -$6.82 -$7.25 -$6.93 -$6.09
Investments $105.32 $24.51 -$6.97 $88.38
Total cash flows from investing $98.5 $17.26 -$13.9 $82.29
Financing activities
Dividends paid
Sale and purchase of stock $1.53 $2.88
Net borrowings -$0 -$0.01
Total cash flows from financing $1.91 $1.17 $7.5 $5.2
Effect of exchange rate $0.2 -$0.1 -$0.01 $0.04
Change in cash and equivalents $86.05 -$0.98 -$29.14 $70.81
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$207.04 -$92.53 -$58.35 $19.81
Operating activities
Depreciation $10.97 $10.62 $10.25 $9.15
Business acquisitions & disposals
Stock-based compensation $115.61 $106.95 $94.9 $75.72
Total cash flows from operations -$73.34 $30.79 $82.76 $99.15
Investing activities
Capital expenditures -$27.09 -$21.36 -$24.17 -$14.97
Investments $211.24 -$118.6 -$120.66 -$457.88
Total cash flows from investing $184.15 -$139.96 -$144.83 -$472.85
Financing activities
Dividends paid
Sale and purchase of stock $4.42 $5.22 $4.55 $3.37
Net borrowings -$0.01 -$0.03 -$0.03 $408.41
Total cash flows from financing $15.79 $15.49 $25.7 $440.21
Effect of exchange rate $0.13 -$0.1 -$0.19 $0.25
Change in cash and equivalents $126.73 -$93.78 -$36.56 $66.76
Fundamentals
Market cap $1.67B
Enterprise value $2.03B
Shares outstanding 107.08M
Revenue $509.34M
EBITDA -$221.90M
EBIT -$232.87M
Net Income -$207.04M
Revenue Q/Q 4.17%
Revenue Y/Y -5.30%
P/E ratio -8.08
EV/Sales 3.98
EV/EBITDA -9.14
EV/EBIT -8.71
P/S ratio 3.29
P/B ratio 4.55
Book/Share 3.44
Cash/Share 2.27
EPS -$1.93
ROA -17.90%
ROE -51.63%
Debt/Equity 2.16
Net debt/EBITDA -2.44
Current ratio 5.78
Quick ratio 5.56